Columnist Juliet Taylor and her late husband, Jeff, fought hard for precious holiday moments after he was diagnosed with ALS.

ALS medication AMX0114 has been well tolerated in early clinical testing, and is now moving to a second, higher-dose trial ...

While briefly changing roles with her husband, columnist Kristin Neva got a glimpse of how frustrating it is to have difficulty speaking.

Neurosense Therapeutics said it will seek conditional approval of PrimeC as an ALS treatment in Canada in mid-2006.

Using adaptive tools and following ALS kitchen safety strategies can make cooking and eating safer when living with ALS.

Slowing down in a fast-paced world while living with ALS isn’t surrendering, writes columnist. It’s an active choice to be ...

Actor Eric Dane is joining nonprofit Target ALS on a campaign aiming to raise $500,000 for ALS research by Dec. 31.

The ALS Association awarded a $1 million grant to support a clinical trial testing Pasithea's MEK inhibitor PAS-004 in people ...

So what happens now? All of a sudden, I was on my own, left to navigate my world, which had changed forever. I was restless, not quite knowing what to do with myself or how to fill my time. I’d just ...

The FDA has authorized a Phase 3 trial of PrimeC, an experimental oral therapy for ALS. In a prior Phase 2b study, PrimeC slowed ALS progression by 37.4% and improved survival by 43% in key patient ...